Latest News and Press Releases
Want to stay updated on the latest news?
-
HOUSTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) today reported operational and financial results for the second quarter of 2022. Highlights and Recent Key...
-
Highlights Significant discovery of spodumene pegmatite outcrop cluster (CV13) located approximately 4.3 km along trend to the southwest of the CV5-1 pegmatite corridor and current drill area A total...
-
U.S. FDA Clearance on Potential Pivotal Phase 2 Trial of ALLO-501A Anticipated in Coming Weeks Expected to be the Industry’s First Allogeneic CAR T Phase 2 Pivotal TrialClearance to Cover ALPHA2...
-
-- 6-month CR in 3 of 6 patients across cohort 1 of the CB-010 ANTLER Phase 1 clinical trial -- -- Additional cohort 1 data expected by YE 2022; enrolling patients in cohort 2 of ANTLER trial -- --...
-
WALTHAM, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate,...
-
Q2 2022 GAAP diluted EPS of $(0.07) and operating income of $3 million Q2 2022 Adjusted diluted EPS of $(0.03)(1) and adjusted operating income of $4 million(1) MINNEAPOLIS, Aug. 08, 2022 (GLOBE...
-
Positive topline data in the Phase 2 BrigHtn trial, demonstrating clinically meaningful and statistically significant reduction in blood pressure with baxdrostat in treatment-resistant hypertension ...
-
HOUSTON, Aug. 08, 2022 (GLOBE NEWSWIRE) -- W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today reported operational and financial results for the second quarter 2022. This press...
-
Successfully met the primary endpoint in the BrigHtn trial, delivering a 20.3 mmHg reduction in systolic blood pressure (SBP), or an 11 mmHg (p-value < 0.0001) decline on a placebo-adjusted basis,...
-
VANCOUVER, British Columbia, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Highlights Preliminary Heavy Liquid Separation (“HLS”) tests on drill core from the CV5 Pegmatite (CF21-001 and 002) at two...